Morphocell

Morphocell is a biotech company in Montreal, United States, founded in 2018. It has raised $50.0M across 2 rounds, most recently a $10.0M Extension Round in December 2025.

Engineering Hope for Adults and Children with Liver Disease

Headquarters
Montreal
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$50.0M
Last Round
$10.0M Extension RoundDec 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Morphocell Technologies is a Montreal-based regenerative medicine company developing the world's first effective cell-based treatments for severe liver diseases in adults and children. The company's lead product, ReLiver, uses iPSC-derived, tissue-engineered liver constructs to replace or supplement failing liver function without the need for invasive surgery or donor organ transplants. Morphocell completed a US$50 million Series A financing round in late 2025 and is advancing its platform through preclinical and clinical development. The company was co-founded by pediatric transplant hepatologist Dr. Massimiliano Paganelli.

Summary

It lists 11–50 employees. It has raised $50.0M in total across 2 rounds, most recently a $10.0M Extension Round in Dec 2025. Investors include Investissement Québec and CDP Venture Capital SGR.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundSeries A Add-onDec 2025
$10.0M

Sign up to see all 2 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Morphocell on Indexed.vc
<a href="https://indexed.vc/companies/morphocell"><img src="https://indexed.vc/api/badge/company/morphocell" alt="Morphocell on Indexed.vc" width="260" height="76" /></a>